Neuronal activity induces CDK5-dependent tau phosphorylation and packaging into exosomes. Selective CDK5 inhibition prevents loading and reduces trans-synaptic tau spreading. Requires development of selective CDK5 inhibitors (not pan-CDK inhibitors like dinaciclib).
## **Molecular Mechanism and Rationale**
The cyclin-dependent kinase 5 (CDK5) represents a critical regulatory node in neuronal function, operating through its obligate activators p35 and p25 to orchestrate diverse cellular processes including neuronal migration, synaptic plasticity, and cytoskeletal dynamics. At presynaptic terminals, CDK5 activation occurs in response to neuronal activity through calcium-dependent signaling cascades that involve calpain-mediated cleavage of p35 to the more st
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
CDK5 recurs across 2 selected hypotheses with aligned directionality in biomarker, unspecified mechanism.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
5/11
dimensions won
CDK5 Inhibition Blocks Activity-Dependen
8/11
dimensions won
CDK5 Inhibition at Presynaptic Terminals
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.78
Evidence
0.68
0.72
Novelty
0.70
0.68
Feasibility
0.52
0.58
Impact
0.72
0.75
Druggability
0.45
0.42
Safety
0.42
0.38
Competition
0.72
0.72
Data
0.65
0.74
Reproducible
0.62
0.65
KG Connect
0.50
0.50
Score Breakdown
Dimension
CDK5 Inhibition Blocks Activit
CDK5 Inhibition at Presynaptic
Mechanistic
0.700
0.780
Evidence
0.680
0.720
Novelty
0.700
0.680
Feasibility
0.520
0.580
Impact
0.720
0.750
Druggability
0.450
0.420
Safety
0.420
0.380
Competition
0.720
0.720
Data
0.650
0.740
Reproducible
0.620
0.650
KG Connect
0.500
0.500
Evidence
CDK5 Inhibition Blocks Activity-Dependent Tau Propagation
No evidence citations yet
CDK5 Inhibition at Presynaptic Terminals Prevents Activity-D
No evidence citations yet
Debate Excerpts
CDK5 Inhibition Blocks Activity-Dependent Tau Prop
4 rounds · quality: 0.77
Theorist
# Test Preregistration: Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: Microglial TREM2 Activation as Therapeutic Target in Alzheimer's Disease
**Title:** TREM2 agonism will reduce amy...
Skeptic
# Skeptic's Evaluation: Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: TREM2 Agonism
**Weakest link:** R47H is a *loss-of-function* variant—agonism restores WT signaling, but does pharmaco...
{
"ranked_hypotheses": [
{
"title": "NRF2 Activation Provides Neuroprotection Across ALS, AD, and PD",
"description": "Genetic or pharmacologic NRF2 activation using CDDO-EA or sulfo...
CDK5 Inhibition at Presynaptic Terminals Prevents
4 rounds · quality: 0.73
Theorist
# Therapeutic Hypotheses: Prion-Like Spreading of Tau Pathology Through Connected Brain Regions
## Hypothesis 1: Exosome-Mediated Transsynaptic Tau Propagation via LRP1 Receptor Targeting
**Title:**...
Skeptic
# Critical Evaluation of Tau Spreading Hypotheses
## Hypothesis 1: LRP1-Mediated Exosomal Tau Uptake
### Weak Links
**Receptor Specificity Problem:** LRP1 is a multiligand receptor recognizing >40 ...
Domain Expert
# Feasibility Assessment: Prion-Like Tau Spreading Hypotheses
## Executive Summary
After integrating the theorist's mechanistic proposals with the skeptic's counterarguments, the seven hypotheses sp...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "CDK5 Inhibition at Presynaptic Terminals Prevents Activity-Dependent Tau Release and Transsynaptic Propagation",
"description": "Neuronal...